ADMS - Premarket analyst action - healthcare October, 05 2018 08:48 AM Adamas Pharmaceuticals Inc. Natera (NASDAQ:NTRA) initiated with Neutral rating and $26 (11% upside) price target at JPMorgan. More news on: Natera, Evolent Health, Eli Lilly and Company, Healthcare stocks news, Stocks on the move, , Read more ...